QOP
ARNA

Quinn Opportunity Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Quinn Opportunity Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,000
Closed -$372K – 225
2021
Q4 		$372K Buy
+4,000
New +$264K 0.02% 169

Quinn Opportunity Partners's ARNA Position: Q1 2022 in Review

Quinn Opportunity Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,000 shares — an estimated $372K sold.

Quinn Opportunity Partners first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $372K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Quinn Opportunity Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Quinn Opportunity Partners sold 4,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $372K.
  • Quinn Opportunity Partners first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Quinn Opportunity Partners's Arena Pharmaceuticals Inc position peaked at $372K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Quinn Opportunity Partners's 13F filing for Q1 2022, filed 16 May 2022.